Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid
- 18 December 2007
- journal article
- research article
- Published by Elsevier
- Vol. 30 (7) , 1069-1077
- https://doi.org/10.1016/j.neurobiolaging.2007.10.012
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivoNature Medicine, 2006
- Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer β-amyloid pathologyJournal of Inorganic Biochemistry, 2006
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyPublished by Elsevier ,2006
- Radioiodinated clioquinol as a biomarker for β‐amyloid: Zn2+ complexes in Alzheimer's diseaseAging Cell, 2006
- Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injuryExperimental Neurology, 2005
- Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's diseaseAnnals of Neurology, 2005
- Cerebrospinal fluid levels of transition metals in patients with Alzheimer's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- Zinc-induced Alzheimer's Aβ1–40 Aggregation Is Mediated by Conformational FactorsJournal of Biological Chemistry, 1997
- α2‐Macroglobulin as a β‐Amyloid Peptide‐Binding Plasma ProteinJournal of Neurochemistry, 1997
- Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging StudyJAMA, 1996